Pulse Biosciences (PLSE)
NASDAQ:PLSE

Pulse Biosciences (PLSE) Income Statement

174 Followers

Pulse Biosciences Income Statement

Last quarter (Q2 2023), Pulse Biosciences's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q2, Pulse Biosciences's net income was $-9.91M. See Pulse Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ -9.00K$ 700.00K$ 1.42M$ 0.00$ 0.00$ 0.00
Cost of Revenue
$ 7.11M$ 11.94M$ 1.97M$ 0.00--
Gross Profit
$ -9.70M$ -11.24M$ -550.00K$ 0.00--
Operating Expense
$ 17.73M$ 46.81M$ 62.46M$ 49.97M$ 47.95M$ 37.96M
Operating Income
$ -27.43M$ -58.06M$ -63.01M$ -49.97M$ -47.95M$ -37.96M
Net Non Operating Interest Income Expense
$ -388.00K$ -448.00K$ -646.00K$ 114.00K$ 983.00K$ 446.00K
Other Income Expense
-----$ -28.00K
Pretax Income
$ -46.95M$ -58.51M$ -63.66M$ -49.85M$ -46.97M$ -37.55M
Tax Provision
$ -3.00K$ -3.00K$ -3.00K$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -27.82M$ -58.51M$ -63.66M$ -49.85M$ -46.97M$ -37.55M
Basic EPS
$ -1.76$ -1.72$ -2.28$ -2.14$ -2.26$ -2.20
Diluted EPS
$ 0.54$ -1.72$ -2.28$ -2.14$ -2.26$ -2.20
Basic Average Shares
$ 153.00M$ 33.94M$ 27.96M$ 23.25M$ 20.75M$ 17.08M
Diluted Average Shares
$ 119.06M$ 33.94M$ 27.96M$ 23.25M$ 20.75M$ 17.08M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 24.84M$ 58.76M$ 64.43M$ 49.97M$ 47.95M$ 37.96M
Net Income From Continuing And Discontinued Operation
$ -46.95M$ -58.51M$ -63.66M$ -49.85M$ -46.97M$ -37.55M
Normalized Income
$ -25.87M--$ -49.85M$ -46.97M$ -37.55M
Interest Expense
------
EBIT
$ -46.48M$ -58.51M$ -63.66M$ -49.97M$ -47.95M$ -37.96M
EBITDA
$ -45.18M$ -57.15M$ -62.51M$ -48.87M$ -46.79M$ -36.65M
Currency in USD

Pulse Biosciences Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis